Cargando…
Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411121/ https://www.ncbi.nlm.nih.gov/pubmed/36008490 http://dx.doi.org/10.1038/s41467-022-32722-1 |
_version_ | 1784775249412227072 |
---|---|
author | Gao, Jing Hou, Bo Zhu, Qiwen Yang, Lei Jiang, Xingyu Zou, Zhifeng Li, Xutong Xu, Tianfeng Zheng, Mingyue Chen, Yi-Hung Xu, Zhiai Xu, Huixiong Yu, Haijun |
author_facet | Gao, Jing Hou, Bo Zhu, Qiwen Yang, Lei Jiang, Xingyu Zou, Zhifeng Li, Xutong Xu, Tianfeng Zheng, Mingyue Chen, Yi-Hung Xu, Zhiai Xu, Huixiong Yu, Haijun |
author_sort | Gao, Jing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9411121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94111212022-08-27 Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy Gao, Jing Hou, Bo Zhu, Qiwen Yang, Lei Jiang, Xingyu Zou, Zhifeng Li, Xutong Xu, Tianfeng Zheng, Mingyue Chen, Yi-Hung Xu, Zhiai Xu, Huixiong Yu, Haijun Nat Commun Author Correction Nature Publishing Group UK 2022-08-25 /pmc/articles/PMC9411121/ /pubmed/36008490 http://dx.doi.org/10.1038/s41467-022-32722-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Gao, Jing Hou, Bo Zhu, Qiwen Yang, Lei Jiang, Xingyu Zou, Zhifeng Li, Xutong Xu, Tianfeng Zheng, Mingyue Chen, Yi-Hung Xu, Zhiai Xu, Huixiong Yu, Haijun Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title | Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title_full | Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title_fullStr | Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title_full_unstemmed | Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title_short | Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy |
title_sort | author correction: engineered bioorthogonal poly-protac nanoparticles for tumour-specific protein degradation and precise cancer therapy |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411121/ https://www.ncbi.nlm.nih.gov/pubmed/36008490 http://dx.doi.org/10.1038/s41467-022-32722-1 |
work_keys_str_mv | AT gaojing authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT houbo authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT zhuqiwen authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT yanglei authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT jiangxingyu authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT zouzhifeng authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT lixutong authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT xutianfeng authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT zhengmingyue authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT chenyihung authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT xuzhiai authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT xuhuixiong authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy AT yuhaijun authorcorrectionengineeredbioorthogonalpolyprotacnanoparticlesfortumourspecificproteindegradationandprecisecancertherapy |